Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
267
datasets available to search
ShareScore release 0.9.0
Dataset results
267 results for “Biliary tract cancer”
Irinotecan and Capecitabine as Second-line Treatment for Advanced/Metastatic Biliary Tract Cancers
ClinicalTrials.gov study NCT02720601. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib/II Single-arm Study of mFOLFOX6, Bevacizumab and Atezolizumab in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05052099. IPD Sharing: NO. Countries: 2. Publications: 0.
Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT04111380. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06465563. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study of S-1 Oxaliplatin (SOX) for Biliary Tract Cancer (BTC) (Ampullary Adenocarcinoma)
ClinicalTrials.gov study NCT01180153. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）
ClinicalTrials.gov study NCT05781074. IPD Sharing: NO. Countries: 1. Publications: 0.
Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)
ClinicalTrials.gov study NCT06109779. IPD Sharing: YES. Countries: 21. Publications: 0.
Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer
ClinicalTrials.gov study NCT01815307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
ClinicalTrials.gov study NCT06467357. IPD Sharing: YES. Countries: 27. Publications: 0.
The Role of ctDNA and PBMC in Treatment of Biliary Tract Cancer
ClinicalTrials.gov study NCT02809898. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Phase II Trial of Preoperative Chemotherapy for Biliary Tract Cancer (BTC) With Node Metastasis
ClinicalTrials.gov study NCT01821248. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer
ClinicalTrials.gov study NCT05640791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Randomized Trial of SLOG vs GC in Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT03406299. IPD Sharing: NO. Countries: 1. Publications: 0.
Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer
ClinicalTrials.gov study NCT00832689. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1 Clinical Trial to Evaluate the Safety of Allogeneic NK Cell ("SMT-NK") Cell Therapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT03358849. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients
ClinicalTrials.gov study NCT06529718. IPD Sharing: YES. Countries: 2. Publications: 0.
FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study
ClinicalTrials.gov study NCT03110510. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unresectable or Recurrent Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT06413745. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
TST001 in Patients With CLDN18.2 Positive Previously Treated Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT05190575. IPD Sharing: NO. Countries: 1. Publications: 0.
GEMOX Combined With Donafenib and Tislelizumab in Biliary Tract Cancer
ClinicalTrials.gov study NCT04979663. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.